Filling the need for trusted information on health issues…

Trending on kff Enrollment Marketplaces Medicare Advantage

Private Sector Involvement

  • your selections
Clear Search

Filter Results

date

Tags

  • results
Also In Global Health News: Reducing Violence Against Women; Bartering For Medical Care In Zimbabwe; Guinea Worm Eradication; Childhood Vaccination Successes, Challenges

AOL News Examines Fight Against Domestic Violence, Private Sector Role AOL News examines how the U.N. is working to include corporations in the effort to reduce domestic violence against women, which “includes beatings, rape, human trafficking and female genital mutilation.” According to the article, “more than 100 countries still don’t have laws against domestic…

Recent Releases In Global Health

Here is a sampling of blog posts analyzing the  Quadrennial Diplomacy and Development Review (QDDR) after it was released on Wednesday: Council on Foreign Relations: Weighing an Ambitious QDDR (Garrett et al., 12/16); CGD’s “Rethinking U.S. Foreign Assistance Blog”: The QDDR: Whew, It’s Done (Or Is It?) (Veillette, 12/16); State Department’s…

Also In Global Health News: Malaria Vaccine; Brazil’s Progress Toward MDGs; Malnutrition In Guatemala; Treatments For Kala-Azar

PATH, Merck, NYU To Work Together On Development Of Vaccine To Keep Malaria Parasite From Entering Liver The PATH Malaria Vaccine Initiative (MVI), pharmaceutical company Merck and New York University’s Langone Medical Center on Tuesday announced they were collaborating “to develop a vaccine capable of preventing the malaria parasite from…

Reuters Examines Investors’ Interests In Bonds That Support GAVI Alliance

“It’s not only biologists, philanthropists and donor governments who are needed to make vaccine projects in poor countries work. Financial engineers … also have a role,” Reuters writes in an article that examines how “a new kind of bond issue” is helping to support the GAVI Alliance.

Also In Global Health News: Clinical Trial Participants Abroad; PMTCT Project In Malawi; Congo Polio Outbreak; Global Fund Zambia Grant; Women, Girls In Afghanistan

Lancet World Report Examines Protections In Place For Clinical Trial Participants Abroad Lancet World Report, in a follow-up on the revelations over the U.S.’s role in medical experiments conducted on Guatemalan prisoners in the 1940s writes: “A thorough review of the safeguards in place to protect modern human trial participants…

EU, India Leaders Meet To Discuss Trade Deal, Some Concerned Deal Will Jeopardize Drug Access In Developing Countries

On Friday, Indian Commerce Minister Anand Sharma and EU Trade Commissioner Karel de Gucht met to “present a status report on the ongoing free trade talks” that some health advocates fear could limit the supply of generic medications in developing countries, according to Business Standard. “An EU source said the report would signal that talks had made excellent progress and should be wrapped up by early next year,” according to the news service (Aiyar, 12/10).

NIH To Create New Translational Science Center

National Institutes of Health (NIH) Director Francis Collins on Tuesday announced the agency is moving forward on plans to create a new research center focused on translational science, after NIH’s advisory board voted to create the new center, Science’s “Science Insider” reports (Kaiser, 12/7).

India, EU Trade Agreement Will Not Restrict Ability For India Pharmaceutical Firms To Export Generic Drugs, Official Says

“India and the European Union (EU) have agreed that the comprehensive bilateral trade agreement being negotiated by the two will not result in an intellectual property regime that restricts the ability of Indian pharmaceutical firms to export generic or off-patent drugs by being far more stringent than the TRIPS [Trade-Related Aspects of International Property Rights] regime of the World Trade Organization,” LiveMint.com reports in an article that describes recent debates over the agreement. “The two sides agreed to this at a meeting between Indian trade minister Anand Sharma and his counterpart in the European Commission (EC), Karel De Gucht, at Brussels on 29 November, said a senior commerce ministry official on condition of anonymity,” the news service reports.

Media Examines Efforts To Protect Patients In Africa From Counterfeit Medications

HP and the African social enterprise mPedigree on Monday announced a new service that will enable patients in Ghana and Nigeria to verify the authenticity of their medications, Fast Company reports. “Counterfeit drugs are estimated to be a $75-billion-per-year business, [and are] implicated in the deaths of something like 700,000 people around the world annually,” according to the article (Zax, 12/6).